NCT07393425 2026-02-06Neoadjuvant Trastuzumab Deruxtecan (SHR-A1811) + Pertuzumab in HER2+ Breast CancerShanghai Jiao Tong University School of MedicinePhase 2 Recruiting50 enrolled
NCT07340398 2026-01-21TAYLORSecond Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 2 Recruiting200 enrolled